Heart disease in Friedreich’s ataxia

• 作者: Brenda Pacheco Emily Hanson Mark Sheldon Mohammed Alkubeysi Veena Raizada
• 来源期刊: 世界心脏病学杂志:英文版(电子版)
• 学科: 医学
• 关键词: Friedreich’s ATAXIA MITOCHONDRIAL DISORDER Nonischemic CARDIOMYOPATHY CARDIAC DISEASE
• 年，卷（期）: 2019,（1）
• 页码范围: 1-12
• 页数: 12页
• 分类号: R744.7

摘要

Friedreich’s ataxia(FRDA),which occurs in 1/50000 live births,is the most prevalent inherited neuromuscular disorder.Nearly all FRDA patients develop cardiomyopathy at some point in their lives.The clinical manifestations of FRDA include ataxia of the limbs and trunk,dysarthria,diabetes mellitus,and cardiac diseases.However,the broad clinical spectrum makes FRDA difficult to identify.The diagnosis of FRDA is based on the presence of suspicious clinical factors,the use of the Harding criteria and,more recently,the use of genetic testing for identifying the expansion of a triplet nucleotide sequence.FRDA is linked to a defect in the mitochondrial protein frataxin;an epigenetic alteration interferes with the folding of this protein,causing a relative deficiency of frataxin in affected patients.Frataxins are small essential proteins whose deficiency causes a range of metabolic disturbances,including oxidative stress,iron-sulfur cluster deficits,and defects in heme synthesis,sulfur amino acid metabolism,energy metabolism,stress responses,and mitochondrial function.The cardiac involvement seen in FRDA is a consequence of mitochondrial proliferation as well as the loss of contractile proteins and the subsequent development of myocardial fibrosis.The walls of the left ventricle become thickened,and different phenotypic manifestations are seen,including concentric or asymmetric hypertrophy and(less commonly)dilated cardiomyopathy.Dilated cardiomyopathy and arrhythmia are associated with mortality in patients with FRDA,whereas hypertrophic cardiomyopathy is not.Systolic function tends to be low-normal in FRDA patients,with an acute decline at the end of life.However,the literature includes only a few long-term prospective studies of cardiac progression in FRDA,and the cause of death is often attributed to heart failure and arrhythmia postmortem.Cardiomyopathy tends to be correlated with the clinical neurologic age of onset and the nucleotide triplet repeat length(i.e.,markers of phenotypic disease severity)rather than th